Clinical Trials · NCT04379856
Proof of Concept Study in Patients With Short Bowel Syndrome
- Phase
- Phase 1/Phase 2
- Recruitment status
- Unknown
- Sponsor
- 9 Meters Biopharma, Inc.
- Enrollment
- 12
- Start date
- Jun 2020
- Locations
- 1 site, United States
- Primary endpoint
- To assess the safety and tolerability of repeated doses of NM002 three different dose levels